Monte Rosa Therapeutics competitorsClear all

Monte Rosa Therapeutics's top competitors include DNAtriX, OncoQR ML, Lyell and Nkarta Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Monte Rosa Therapeutics
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.
DNAtriX
DNAtriX
DNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer.
OncoQR ML
OncoQR ML
OncoQR ML is a biotech company that develops cancer immunotherapies.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Nkarta Therapeutics
Nkarta Therapeutics
Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer.
Founding Date
Founding Date
2018
Founding Date
2005
Founding Date
2013
Founding Date
2018
Founding Date
2015
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Boston, US HQ
Basel, CH
Locations
Houston, US HQ
San Diego, US
Locations
Wien, AT HQ
Irenental, AT
Wien, AT
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Locations
South San Francisco, US HQ
Employees
Employees
75
Employees
254% increase
Employees
3
Employees
188
Employees
1152% decrease
Valuation ($)
Valuation ($)
1 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
3.4 b
Valuation ($)
N/A
Twitter followers
Twitter followers
361
Twitter followers
206
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
379658
Alexa Website Rank
562840
Alexa Website Rank
N/A
Alexa Website Rank
366493
Alexa Website Rank
254850
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4
Employee Rating
5

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 15.5m (about 3 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 114m (about 2 years ago)
Total funding raised
Total funding raised
$ 223.5m
Total funding raised
$ 54.2m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 125m
For sources of this data, please see the company profile

View company profiles

DNAtriX
HQ
Houston, US
Employees
25↑ 4% increase

DNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer.

View company
OncoQR ML
HQ
Wien, AT
Employees
3

OncoQR ML is a biotech company that develops cancer immunotherapies.

View company
Lyell
HQ
South San Francisco, US
Employees
188

Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.

View company
Nkarta Therapeutics
HQ
South San Francisco, US
Employees
115↓ 2% decrease

Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer.

View company